Prevalence and Underlying Etiologies of Neonatal Hypoglycemia
This study aims at determining the prevalence of neonatal hypoglycemia and its underlying causes. In this prospective study 14168 newborns delivered in Tabriz Alzahra Hospital during 2 years were evaluated in regard to blood glucose level at first 24 h of life. Glucose oxidase method with 4-amino-phenazone with a Greiner G-300 was the used method for determining the blood glucose level. Cases with blood glucose <50 mg dL-1 were considered as hypoglycemic newborns. Underlying causes of this condition, as well as the short-term mortality rate were determined. Prevalence of neonatal hypoglycemia was 0.4% (52 newborns). Underlying causes of hypoglycemia were prematurity (61.5%), diabetic mother (13.6%), septicemia (9.6%), perinatal asphyxia (9.6%), stress (3.8%) and neonatal hyperinsulinism (1.9%). The mortality rate was 53.8%, with prematurity as the leading cause of death.
Received: May 24, 2010;
Accepted: July 16, 2010;
Published: August 05, 2010
Hypoglycemia is a common abnormality in newborns (Kinnala
et al., 2000). It is almost 4 decades since Cornblath and Reisner
described hypoglycemia as a significant cause of mortality and morbidity in
newborns (Deshpande and Ward Platt, 2005). Many hypoglycemic
infants remain asymptomatic. Prolonged or severe hypoglycemia causes both adrenergic
and neuroglycopenic signs. Adrenergic signs include diaphoresis, tachycardia,
lethargy or weakness and shakiness. Neuroglycopenic signs include seizure, coma,
cyanotic episodes, apnea, bradycardia or respiratory distress and hypothermia.
Listlessness, poor feeding, hypotonia and tachypnea may occur (Beers
and Berkow, 2000). Delay in treatment may lead to significant neurologic
consequences, such as permanent brain damage or even death (Sperling
and Menon, 2004). Hypoglycemia in the newborn may be associated with both
acute decompensation and long-term neuronal loss (Straussman
and Levitsky, 2010; Suh et al., 2007; Rozance
and Hay, 2006; Vannucci and Vannucci, 2001). This
is mainly because of that the glucose is the major source of energy for neonate.
The newborn brain depends upon glucose almost exclusively. On the other hand,
the glucose regulatory mechanisms are not fully developed in newborns (Kliegman
et al., 2007). Different conditions are in association with neonatal
hypoglycemia including decreased substrate availability such as inborn errors,
prematurity and intra-uterine growth retardation; hyperinsulinemia for example
in infants of diabetic mother, islet cell hyperplasia, erythroblastosis fetalis,
exchange transfusion, Beckwith-Wiedemann Syndrome, maternal β-mimetic tocolytic
agents, high umbilical arterial catheter and abrupt cessation of intravenous
glucose; other endocrine abnormalities such as pan-hypopituitarism, hypothyroidism
and adrenal insufficiency; increased glucose utilization for example in cold
stress, increased work of breathing, sepsis and perinatal asphyxia; and miscellaneous
conditions such as polycythemia, congenital heart disease and central nervous
system abnormalities (Gomella et al., 2009; Cloherty
et al., 2007). Many different factors may affect the prevalence of
neonatal hypoglycemia in different medical centers. So performing specific surveys
in this regard is very important for a center dealing with the neonates. This
study aims at evaluating the prevalence of neonatal hypoglycemia, its underlying
etiologies and short-term mortality rate related to this condition in a referral
center in Iran.
MATERIALS AND METHODS
In this prospective study, 14168 newborns delivered in Tabriz Alzahra Teaching
Hospital, a referral center in North-west of Iran were evaluated during their
first 24 h of life. This study conducted in a two-year period between January
2009 and January 2010. Among these newborn, cases with hypoglycemia were determined.
The 50 mg dL-1 was chosen as the low normal value for blood glucose.
In other words, neonates with blood glucose <50 mg dL-1 was considered
hypoglycemic. For determining the blood glucose level, a standard assay was
performed (glucose oxidase method with 4-amino-phenazone with a Greiner G-300)
by Abbott FreeStyleTM kit, USA. For standard glucose determinations
0.5 mL venous blood (from neonates heel) was mixed in a plastic tube with
sodium fluoride and EDTA. Samples were processed within 1 h (Duvanel
et al., 1999). Blood calcium level was also reported simultaneously
by a standard method. In the cases with hypoglycemia, further evaluations were
performed according to the administrating physicians order per case for
determining the underlying etiology; for example, requesting for blood insulin
level in cases with suspected to have hyperinsulinism, genetic evaluations in
patients with possible related disorders and etc. General evaluations were thorough
physical examination of mother and newborn, assessing the available documents
regarding the pregnancy period events and documenting the past medical history
of mothers. The mortality rate was determined by the time of discharge from
hospital. The main cause of death was investigated in the expired cases. This
study was approved by the Ethics Committee of Tabriz University of Medical Sciences.
Statistical analysis was performed using the SPSS software (USA), version 15.
The data are shown as Mean±SD or frequency (%).
During the study period, 14168 newborns were delivered in this center. Eight
hundred and fifty two newborn were admitted to the Neonatal Care Unit (NICU).
Fifty two newborn (0.4% of all neonates, 6.1% of the NICU patients) were hypoglycemic
during their first 24 h of life. In the hypoglycemic group, 28 (53.8%) patients
were males and 24 (46.2%) patients were female with a male to female ratio of
1.2 to 1. Thirty one (59.6%) newborns were premature. Thirty one (59.6) newborns
were LBW and 21 (40.4%) newborn were VLBW. The mode of delivery was vaginal
in 41 (78.8%) patients and by cesarean section in 11 (21.2%) cases. Accompanying
hypocalcemia was present in 7 (13.5%) newborns. Seizure occurred in 3 of these
patients. Underlying causes of hypoglycemia are summarized in Table
1. Accordingly the most frequent cause was prematurity. The other causes
were diabetes mellitus of mother, septicemia, previous asphyxia, stress and
neonatal hyperinsulinism in a decreasing order. Twenty eight (53.8%) newborns
expired during the hospitalization. This mortality rate is shown in Fig.
|| Etiologies of hypoglycemia in the studied neonates
|| Etiologies of mortality in hypoglycemic newborns
||Percentages of expired and discharged hypoglycemic newborns
Underlying causes of mortality are summarized in Table 2.
Accordingly the most frequent cause of death was prematurity. The other causes
were respiratory distress syndrome, septicemia and perinatal asphyxia in a decreasing
Prevalence of neonatal hypoglycemia: In current study, the prevalence
of neonatal hypoglycemia was determined in a referral teaching center. In a
2-year period, the prevalence of this condition was 0.4% of all born neonates
and 6.1% of newborns admitted to NICU during the first 24 h of life. All these
hypoglycemic newborns were LBW or VLBW. The range of prevalence is varied in
different reports. Johnson (2003) reported the neonatal
hypoglycemia as a common problem affecting 3 to 29% of all pregnancies. As seen,
the rate of current study is much less. Burdan et al.
(2009) evaluated 2687 newborns during 2 years and reported a prevalence
of 4.6% for the neonatal hypoglycemia in this series. The rate is more than
10 times higher than our result. In another study by DePuy
et al. (2009), there were 4892 term infants weighing> 2500 g born
to nondiabetic mothers over a 2-year period. One hundred and sixteen (2.4%)
infants had neonatal hypoglycemia within the first 24 h of life. Although the
normal term newborns have been recruited in this study, the rate is higher than
ours. Summing up the mentioned reports, prevalence of hypoglycemic newborns
(whiting the first 24 h after delivery) ranges between 3 and 29% in different
settings. In comparison, the relevant prevalence in our study was out of this
range; i.e., the prevalence of neonatal hypoglycemia within the first 24 h after
delivery was much lower than the minimum rate reported by similar studies. This
difference may be justified in different ways. Employment of different definitions
for hypoglycemia in infant newborns is a probable cause of heterogeneity. For
example, in a study by DePuy et al. (2009) the
prevalence of neonatal hypoglycemia was 2.4% when the recorded blood sugar was
considered <50 mg dL-1. Defining hypoglycemia using the cutoff
of ≤40 mg dL-1 reduced the prevalence in their sample population
to 1.6%. In our study, the cut-off point in definition of hypoglycemia was blood
glucose <50 mg/dl. So if we considered a lower cut-off point in this regard,
the prevalence of the condition would more decline. But raising the cut-off
point to a higher level, on the other hand, decreases probability of missing
cases with milder hypoglycemia; so the mentioned approach has been considered
as the main protocol in our center in this regard. The patients health
condition is considered to be another key factor in this regard (Glaser,
2000). Duvanel et al. (1999) evaluated 85
Small for Gestational Age (SGA) preterm newborns. The incidence of hypoglycemia
in this series was 73%, which is more than our finding and the rates reported
by other mentioned studies. They concluded that the prevalence of hypoglycemia
differs greatly in different studies depending on the recruited population.
In the term infants, they reported that the prevalence of hypoglycemia varies
between 0.7 and 11.4%. It seems that the latter range is closer to our finding.
It should be reminded here that 61.5% of studied newborns in our population
were preterm infants. Likewise, all the hypoglycemic newborns were LBW or VLBW.
It is well-known that hypoglycemia is very common in the premature infants comparing
with the term newborns (Garg and Devaskar, 2006). So,
other factors may contribute to the heterogeneity of reports in this regard,
as well. It is assumed that the repetitional measurements for hypoglycemia during
the first 24 h of life may increase the sensitivity of study by enhancing the
screening power (Duvanel et al., 1999). This
may be a underlying factor in this regard, because we did not use a repetitional
approach. On the other hand, methods of incidence calculation are rarely reported
(Johnson, 2003). This may raise doubt on some reported
figures in this regard. Nevertheless, the prevalence of neonatal hypoglycemia
in current study was lower than that in the literature. Further studies in other
similar centers may help to elucidate the issue.
Etiology of neonatal hypoglycemia: We also investigated possible underlying
etiologies of neonatal hypoglycemia in present study. Based on our findings,
the most frequent cause of hypoglycemia was prematurity. The other underlying
causes were diabetes mellitus of mother, septicemia, previous asphyxia, stress
and neonatal hyperinsulinism in a decreasing order. In a study by Burdan
et al. (2009), the most frequent pathologies associated with neonatal
hypoglycemia were perinatal hypoxia, neonatal hypothermia, respiratory distress,
sepsis, neonatal shock and polycytemia in a decreasing order. Comparing with
our findings, perinatal hypoxia, hypothermia (neonatal stress) and sepsis are
mentioned in both reports with different frequencies. Hernandez-Herrera
et al. (2006) showed an increased prevalence of asymptomatic neonatal
hypoglycemia in offspring of women with diabetes mellitus in their early hours
of life. As mentioned earlier, diabetic mother was the second frequent etiology
of neonatal hypoglycemia in our study. To the best of knowledge, there are not
other similar reports in this regard. So, conducting studies in similar centers
is again highly recommended.
Etiology of mortality: We also assessed the underlying cause of death
in neonates with hypoglycemia in present study. Surprisingly, 53.8% of these
newborns expired during their hospital stay. Although it is previously concluded
that the hypoglycemia is an important medical issue in neonates, to our knowledge,
there is not yet a report about the exact mortality rate (Barkovich
et al., 1998). This is probably due to complexity of health condition
in these patients. In other words, due to presence of diverse abnormalities
along with hypoglycemia in these newborns, determining the exact cause of death
is almost impossible. Nevertheless, this high mortality rate necessitates high
caution and special cares in these infants which was the main aim of this study.
Prevalence of neonatal hypoglycemia is lower than that in the literature; however, the mortality rate is considerable. So, it should be born in mind that screening is very important due to high mortality rate. Further studies in similar centers should be undertaken, because there is very limited number of reports in this regard.
1: Barkovich, A.J., F.A. Ali, H.A. Rowley and N. Bass, 1998. Imaging patterns of neonatal hypoglycemia. AJNR. Am. J. Neuroradiol., 19: 523-528.
PubMed | Direct Link |
2: Beers, M.H. and B. Berkow, 2000. The Merck Manual of Diagnosis and Therapy. 17th Edn., John Wiley and Sons, New York.
3: Burdan, D.R., V. Botiu and D. Teodorescu, 2009. Neonatal hypoglycemia-the incidence of the risk factors in salvator vuia obstetrics-gynecology hospital, Arad. TMJ., 9: 77-80.
Direct Link |
4: Cloherty, J.P., E.C. Eichenwald and A.R. Stark, 2007. Manual of Neonatal Care, North American. 6th Edn., Williams and Wilkins Lippincott, ISBN-10: 0781769841.
5: DePuy, A.M., K.M. Coassolo, D.A. Som and J.C. Smulian, 2009. Neonatal hypoglycemia in term, nondiabetic pregnancies. Am. J. Obstet. Gynecol., 200: e45-51.
6: Deshpande, S. and M. Ward Platt, 2005. The investigation and management of neonatal hypoglycaemia. Semin. Fetal. Neonatal. Med., 10: 351-361.
PubMed | Direct Link |
7: Duvanel, C.B., C.L. Fawer, J. Cotting, P. Hohlfeld and J.M. Matthieu, 1999. Long-term effects of neonatal hypoglycemia on brain growth and psychomotor development in small-for-gestational-age preterm infants. J. Pediatr., 134: 492-498.
PubMed | Direct Link |
8: Glaser, B., 2000. Hyperinsulinism of the newborn. Semin. Perinatol., 24: 150-163.
PubMed | Direct Link |
9: Gomella, T., M. Cunningham, F. Eyal, T.L. Gomella, M.D. Cunningham and F. Eyal, 2009. Neonatology: Management, Procedures, On-Call Problems, Diseases and Drugs. 6th Edn., McGraw-Hill Professional, New York, ISBN-10: 0071544313.
10: Hernandez-Herrera, R., N. Castillo-Martinez, M.E. Banda-Torres, G. Alcala-Galvan, H.E. Tamez-Perez and G. Forsbach-Sanchez, 2006. Hypoglycemia in the newborns of women with diabetes mellitus. Rev. Invest. Clin., 58: 285-288.
PubMed | Direct Link |
11: Johnson, T.S., 2003. Hypoglycemia and the full-term newborn: How well does birth weight for gestational age predict risk. J. Obstet. Gynecol. Neonatal. Nurs., 32: 48-57.
PubMed | Direct Link |
12: Kinnala, A., H. Korvenranta and R. Parkkola, 2000. Newer techniques to study neonatal hypoglycemia. Semin. Perinatol., 24: 116-119.
PubMed | Direct Link |
13: Kliegman, R.M., R.E. Behrman, H.B. Jenson and B. Stanton, 2007. Nelson Textbook of Pediatrics. 18th Edn., Saunders, UK., ISBN-10: 1416040048.
14: Rozance, P.J. and W.W. Hay, 2006. Hypoglycemia in newborn infants: Features associated with adverse outcomes. Biol. Neonate., 90: 74-86.
15: Sperling, M.A. and R.K. Menon, 2004. Differential diagnosis and management of neonatal hypoglycemia. Pediatr. Clin. North. Am., 51: 703-723.
PubMed | Direct Link |
16: Garg, M. and S.U. Devaskar, 2006. Glucose metabolism in the late preterm infant. Clin. Perinatol., 33: 853-870.
17: Suh, S.W., A.M. Hamby and R.A. Swanson, 2007. Hypoglycemia, brain energetics and hypoglycemic neuronal death. Glia, 55: 1280-1286.
18: Vannucci, R.C. and S.J. Vannucci, 2001. Hypoglycemic brain injury. Semin. Neonatol., 6: 147-155.
19: Straussman, S. and L.L. Levitsky, 2010. Neonatal hypoglycemia. Curr. Opin. Endocrinol. Diabetes Obes., 17: 20-24.